Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer

Phase 1

Recruiting

Conditions: Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma

Interventions: Biological: durvalumab
Drug: carboplatin AUC 2/paclitaxel
Radiation: External beam radiation (EBRT)
Procedure: esophagogastrectomy
Drug: Tremelimumab

First Posted Date: 2016-11-11

Last Posted Date: 2024-10-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 79

Registration Number: NCT02962063

Locations: 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 4 locations

Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer

Phase 2

Completed

Conditions: Esophageal Cancer
Gastric Cancer

Interventions: Drug: pembrolizumab
Drug: trastuzumab
Drug: capecitabine
Drug: cisplatin
Drug: Oxaliplatin
Drug: 5-Fluorouracil

First Posted Date: 2016-11-03

Last Posted Date: 2023-03-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 37

Registration Number: NCT02954536

Locations: 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 5 locations

Interest and Impact of Skin Cancer Genetic Testing

Completed

Conditions: Non-melanoma Skin Cancer (NMSC)

Interventions: Genetic: MC1R genotyping
Behavioral: MC1R Testing Website
Behavioral: Baseline Survey

First Posted Date: 2016-10-21

Last Posted Date: 2023-01-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 53

Registration Number: NCT02941900

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

High Dose Carfilzomib for Newly Diagnosed Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Carfilzomib
Drug: Lenalidomide
Drug: Dexamethasone

First Posted Date: 2016-10-18

Last Posted Date: 2024-10-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 37

Registration Number: NCT02937571

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 2 locations

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

Phase 1

Active, not recruiting

Conditions: Central Nervous System Tumor
Solid Tumor
Leukemia
Lymphoma

Interventions: Drug: Neratinib

First Posted Date: 2016-10-13

Last Posted Date: 2024-12-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 14

Registration Number: NCT02932280

Locations: 🇺🇸
University of Texas, San Antonio, Texas, United States
🇺🇸
Huntsman Cancer Institue, Salt Lake City, Utah, United States
🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States

and more 6 locations

Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their Caregivers

Active, not recruiting

Conditions: Post Hematopoietic Stem Cell Transplantation

Interventions: Behavioral: semi-structured interviews

First Posted Date: 2016-10-10

Last Posted Date: 2024-08-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 41

Registration Number: NCT02928185

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study

Completed

Conditions: Primary Peritoneal Cancer
Fallopian Tube Cancer
Ovarian Cancer

Interventions: Behavioral: semi-structured interviews

First Posted Date: 2016-10-10

Last Posted Date: 2019-08-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT02928549

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients

Not Applicable

Completed

Conditions: Neuroblastoma

Interventions: Drug: ropivacaine
Device: propofol
Behavioral: Wong-Baker FACES® Pain Rating Scale
Behavioral: Post-procedural quality of life (QOL)

First Posted Date: 2016-10-05

Last Posted Date: 2022-11-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 56

Registration Number: NCT02924324

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Trial of YUMI Uterine Manipulator

Not Applicable

Completed

Conditions: Scheduled for a Total Laparoscopic or Robotic-assisted Hysterectomy
Gynecologic Condition

Interventions: Procedure: YUMI manipulator

First Posted Date: 2016-10-04

Last Posted Date: 2022-05-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT02923544

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent and Follow-Up only), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent and Follow-Up only), Harrison, New York, United States

and more 4 locations

Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer

Phase 2

Recruiting

Conditions: Head and Neck Cancer

Interventions: Radiation: Proton beam radiotherapy (PBRT)
Radiation: Photon intensity modulated radiation therapy (IMRT)

First Posted Date: 2016-10-04

Last Posted Date: 2024-07-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 108

Registration Number: NCT02923570

Locations: 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

and more 6 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy